Case Report: The Imperfect Association Between Craniofacial Lesion Burden and Pain in Fibrous Dysplasia
暂无分享,去创建一个
Nehal A Shah | Nehal A. Shah | C. Westin | Daryl J. Selen | H. Kronenberg | J. Upadhyay | L. Kaban | Lauren O’Donnell | L. Drubach | A. Boyce | Lauren J. O’Donnell | D. Ebb | Emma Golden | Fan Zhang | L. Romo | J. Lemme | R. Myers | Mariesa Cay | L. O’Donnell
[1] K. Digre,et al. Mild traumatic brain injury affects the features of migraine , 2021, The Journal of Headache and Pain.
[2] M. Collins,et al. Denosumab for craniofacial fibrous dysplasia: duration of efficacy and post-treatment effects , 2021, Osteoporosis International.
[3] E. Kraft,et al. Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases , 2021, Neuroscience & Biobehavioral Reviews.
[4] L. Kaban,et al. Natural History and Progression of Craniofacial Fibrous Dysplasia: A Retrospective Evaluation of 114 Patients From Massachusetts General Hospital. , 2020, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[5] Alexandra J. Golby,et al. Creation of a novel trigeminal tractography atlas for automated trigeminal nerve identification , 2020, NeuroImage.
[6] Alexandra J. Golby,et al. Anatomical assessment of trigeminal nerve tractography using diffusion MRI: A comparison of acquisition b-values and single- and multi-fiber tracking strategies , 2020, NeuroImage: Clinical.
[7] P. Dijkstra,et al. Denosumab in Patients with Fibrous Dysplasia Previously Treated with Bisphosphonates. , 2019, The Journal of clinical endocrinology and metabolism.
[8] A. Leithner,et al. Pain in fibrous dysplasia: relationship with anatomical and clinical features , 2019, Acta orthopaedica.
[9] S. Paul,et al. Age‐Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] T. Mom,et al. Craniofacial fibrous dysplasia: A 10-case series. , 2017, European annals of otorhinolaryngology, head and neck diseases.
[11] K. Cook,et al. Development and Validation of a Daily Pain Catastrophizing Scale. , 2017, The journal of pain : official journal of the American Pain Society.
[12] P. Dijkstra,et al. Determinants of impaired quality of life in patients with fibrous dysplasia , 2017, Orphanet Journal of Rare Diseases.
[13] Hyunsook Kim,et al. Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways , 2017, Scientific Reports.
[14] I. Chiodini,et al. Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia. , 2016, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.
[15] Steen Moeller,et al. The Human Connectome Project's neuroimaging approach , 2016, Nature Neuroscience.
[16] K. Kim. Headache Attributed to Fibrous Dysplasia of the Ethmoid Bone Mimicking Menstrual Migraine Without Aura , 2016, The Journal of craniofacial surgery.
[17] D. Haynes,et al. Fibrous dysplasia of the temporal bone: A review of 66 cases , 2015, The Laryngoscope.
[18] R. Chapurlat,et al. Transient improvement of severe pain from fibrous dysplasia of bone with denosumab treatment. , 2014, Joint, bone, spine : revue du rhumatisme.
[19] S. Wientroub,et al. A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. , 2014, The Journal of clinical endocrinology and metabolism.
[20] M. Seibel,et al. Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases , 2014, Osteoporosis International.
[21] A. Molinolo,et al. Effects of denosumab treatment and discontinuation on human growth plates. , 2014, The Journal of clinical endocrinology and metabolism.
[22] J. Lee,et al. Clinical guidelines for the management of craniofacial fibrous dysplasia , 2012, Orphanet Journal of Rare Diseases.
[23] P. Mantyh,et al. Pathophysiology and medical treatment of pain in fibrous dysplasia of bone , 2012, Orphanet Journal of Rare Diseases.
[24] R. Edwards,et al. Pain catastrophizing: a critical review , 2009, Expert review of neurotherapeutics.
[25] Bin Liu,et al. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gsα gene: site‐specific patterns and recurrent histological hallmarks , 1999 .
[26] C. Aring,et al. A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.
[27] T. Seifert. The relationship of migraine and other headache disorders to concussion. , 2018, Handbook of clinical neurology.
[28] Tournis Symeon,et al. The use of bisphosphonates in women prior to or during pregnancy and lactation , 2011 .
[29] M. Kelly,et al. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions , 2007, Osteoporosis International.
[30] P. Trénor,et al. [Fibrous dysplasia in McCune-Albright-syndrome]. , 2005, Revista espanola de medicina nuclear.
[31] John H. Jopson,et al. A REPORT OF TWO CASES , 1902 .